CME Q3 deep dive: diversified volume growth and product innovation underpin results
Financial derivatives exchange CME Group (NASDAQ:CME) announced better-than-expected revenue in Q3 2026, with sales up 13% year on year to $1.74 billion. Its non-GAAP profit of $3.02 per share was 1% above analysts’ consensus estimates.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo